Description
🌿 What It Is | 产品简介
NuFinity Iganbo 60s is a premium dietary supplement formulated with high-quality herbal extracts and targeted nutrients designed to support liver and kidney health, detoxification, and overall wellness. Rich in natural antioxidants and phytonutrients, it helps adults maintain healthy cellular function, natural detox pathways, and overall vitality. The convenient capsule form allows for easy daily supplementation as part of a balanced lifestyle.
NuFinity Iganbo 60 粒 是一款高品质膳食补充剂，精选天然草本提取物及针对性营养成分，旨在支持肝脏与肾脏健康、排毒及整体健康。富含天然抗氧化成分与植物营养素，帮助成年人维持健康的细胞功能、天然排毒通路及整体活力。胶囊形式方便每日服用，适合均衡生活方式下的日常营养补充。
🔬 Key Features & Functions | 核心特性与功能
| Feature 特性 | Function 功能 |
|---|---|
| Herbal & Nutrient Blend
草本与营养复合 |
Supports liver and kidney health / 支持肝脏与肾脏健康 |
| Antioxidant Support
抗氧化支持 |
Helps protect cells from oxidative stress / 有助抵御氧化压力，保护细胞健康 |
| Detox & Cellular Health
排毒与细胞健康 |
Supports natural detoxification and overall cellular wellness
支持天然排毒及整体细胞健康 |
| Liver & Kidney Function
肝肾功能支持 |
Helps maintain normal liver and kidney function
有助维持肝脏及肾脏正常功能 |
| Capsule Form
胶囊形式 |
Easy to swallow and convenient for daily use
易吞服，方便每日服用 |
| 60 Capsules
60 粒 |
Suitable for one to two months of daily supplementation
适合每日服用，约可使用 1–2 个月 |
✨ Benefits | 产品功效
- Supports liver and kidney function
- Provides antioxidant protection and cellular support
- Helps maintain overall wellness and vitality
- Convenient and easy-to-take capsule form
- Ideal for adults seeking targeted liver and kidney support
- 支持肝脏与肾脏功能
- 提供抗氧化保护及细胞支持
- 有助维持整体健康与活力
- 方便服用的胶囊形式
- 适合希望获得针对性肝肾支持的成年人
🧴 How to Use | 使用方法
- Take 1 capsule daily after meals, or as advised by a healthcare professional
- Swallow with sufficient water
- 每日 1 粒，餐后服用，或遵循医师建议
- 配合适量清水吞服
⚠️ Note | 注意事项
- For oral use only
- Do not exceed the recommended daily intake
- Keep out of reach of children
- Consult a healthcare professional if pregnant, nursing, or with medical conditions
- 仅限口服
- 不可超过建议每日摄取量
- 请放置于儿童无法触及之处
- 孕期、哺乳期或有疾病者，使用前请咨询医生
Reviews
There are no reviews yet.